Sutro Biopharma, Inc.

STRO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$190,304$69,268$47,254$30,414
Short-Term Investments$126,591$306,350$287,110$167,524
Receivables$8,616$36,078$7,122$12,454
Inventory$0$0$0$0
Other Curr. Assets$17,799$9,846$11,667$8,123
Total Curr. Assets$343,310$421,542$353,153$218,515
Property Plant & Equip (Net)$35,867$44,755$51,064$51,591
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0-$32,020$68,775
Tax Assets$0$0$0$0
Other NC Assets$8,030$4,439$34,747$2,527
Total NC Assets$43,897$49,194$53,791$122,893
Other Assets$0$0$0$0
Total Assets$387,207$470,736$406,944$341,408
Liabilities
Payables$10,475$9,440$4,797$6,009
Short-Term Debt$7,480$10,481$21,670$10,412
Tax Payable$18$15,165$0$0
Deferred Revenue$69,783$20,666$16,759$5,496
Other Curr. Liab.$44,137$37,994$23,321$19,819
Total Curr. Liab.$131,893$93,746$66,547$41,736
LT Debt$15,674$23,154$33,345$46,962
Deferred Rev, NC$193,345$202,493$89,885$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,694$1,694$119$146
Total NC Liab.$210,713$227,341$123,349$47,108
Other Liabilities$0$0$0$0
Cap. Leases$23,154$29,574$34,159$32,261
Total Liabilities$342,606$321,087$189,896$88,844
Equity
Pref Stock$0$0$0$0
Common Stock$83$61$58$46
Retained Earnings-$786,869-$559,408-$452,615-$333,411
AOCI$39$21-$618-$314
Other Equity$831,348$708,975$670,223$586,243
Total Equity$44,601$149,649$217,048$252,564
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$387,207$470,736$406,944$341,408
Net Debt-$167,150-$35,633$7,761$26,960